Day 1 Stream 1 – Antibody Discovery & Engineering
- Moving beyond mAbs: novel bispecific formats and ADCs
- Novel ADC payloads and conjugation techniques
- Antibody pharmacokinetics (PK) and Pharmacodynamics (PD)
- New antibody discovery platforms
- Single domain and recombinant antibody tools
- Emerging technologies for protein expression: imaging tools, nanodiscs and NMR
- Membrane proteins as key drug targets: overcoming purification and expression hurdles
- The latest updates in protein science: proteomics folding, pathway engineering and protein modification
- Designing the right proteins: combatting cost of goods with early stage drug design
- Novel bispecific antibodies and their therapeutic potential
- Next-generation affinity reagents: recombinant and engineered antibodies, nucleic acid aptamers
- Immuno-oncology: the latest research in targeting solid tumours
- Alternative scaffolds and novel antibody formats
- Reducing protein production timelines with cell line development and novel disposable technologies
- Obtaining reference standards for therapeutic proteins
- Protein stability in pharmaceutical manufacturing: storage concerns and extending ‘shelf life’
- Automation and robotics to enhance processing